Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ECHO trial
2024-511359-16-00Phase 3Authorised
- Sponsor
- Sint Maartenskliniek
- Start
- Nov 2024
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in osteoarthritis (OA) comparing Colchicine with Placebo (2 arms). Primary endpoint: Time from randomization to the first incident of total knee replacement (TKR) or total hip replacement (THR). Planned start Nov 2024; status: authorised.
02
Drugs
colchicine
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on 2024-511359-16-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-511359-16-00.